NewsRoom Articles - Page 456 of 541

ThursdayOct 11, 2018 4:20 pm

420 with CNW – Opioid Alternative Launched in California by Cannabis Company

C3 International recently launched a ground-breaking painkiller derived from cannabis as an alternative to the conventional prescription opioids that have been linked to so many issues, such as the possibility of addiction, constipation, incoherence, loss of appetite and other side effects. The pill made by C3 International is unique because it is a standardized product that can be trusted to deliver the same results at a given dosage for those who use it. The company says that its product doesn’t have any psychoactive ingredients since only CBD was extracted and added to a formulation of other ingredients calculated to provide…

ThursdayOct 11, 2018 9:00 am

Fresh Acquisitions Help Companies Profit from Growth in the Cannabis Sector

CannabisNewsWire Editorial Coverage: A wave of acquisitions is sweeping the cannabis sector, as increasing legalization draws the attention of big business. Large and mid-tier cannabis companies are absorbing their smaller competitors. Tobacco and alcohol companies are moving in as a natural extension of their current ranges. This is supported by growth not just among cannabis growers but also for businesses supporting them. Cultivation supplies company Sugarmade, Inc. (OTC: SGMD) (SGMD Profile) has recently announced the acquisition of hydroponic product companies that could more than double its revenue. Tilray, Inc. (NASDAQ: TLRY) is fueling expansion through an initial public offering as it…

ThursdayOct 11, 2018 9:00 am

CBD Exploding into Mainstream Wellness Products

CannabisNewsWire Editorial Coverage: Bolstered by millennia of anecdotal evidence and ever-mounting scientific validation, cannabidiol (CBD) is rapidly being integrated into myriad mainstream consumer wellness products around the globe. Global cannabis market expected to quadruple to over $63 billion by 2024 CBD oil market to grow at CAGR of 39.19 percent through 2021 CBD products exploding into a wide variety of product lines Diversified, sales-driven companies expected to outpace standard growth curve Humans have used hemp, a variety of Cannabis sativa and a primary source of CBD, for more than 10,000 years in food, textiles and medicine. The world is again…

ThursdayOct 11, 2018 4:20 am

420 with CNW – American Cannabis Producers Fear Canadian Industry Dominance

Cannabis industry players in the U.S. are concerned that the stubborn insistence on prohibition by the federal government will give Canadian producers a chance to dominate the marijuana industry. These sentiments were voiced by Derek Peterson, the CEO of marijuana firm Terra Tech based in California. He revealed that industry players in the U.S. are constrained by many factors which put a damper on their growth and activities. First, cannabis cannot cross state lines since marijuana is still outlawed at the federal level. This restriction means that producers must operate at low capacity just for the market within the state…

WednesdayOct 10, 2018 4:20 pm

420 with CNW – 750 Kilograms of Marijuana Seized By CBP at Canadian Border

Customs and Border Protection officials have announced that they have seized more than 10 shipments of bulk mail from Canada that contained approximately 750 kilograms of marijuana. The seizures started weeks ago when a tractor trailer carrying bulk mail was flagged for additional inspection at the Port Huron entry point in Michigan. A canine unit drew the attention of the border officials to specific packages in the trailer. Further inspection revealed concealed marijuana. Other searches conducted during the subsequent weeks unearthed more cannabis destined for the U.S. and concealed in bulk mail packages. No arrests have so far been made…

WednesdayOct 10, 2018 12:48 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Infuses Cannabis Industry, Delivers Results with Innovative Drug Delivery Platform

Global legal cannabis market projected to surpass $146 billion by end of 2025 Cannabinoid-infused edibles, concentrates represent fastest-growing segment of industry Lexaria’s patented technology improves bio-absorption and bioavailability of active ingredients while masking unpleasant taste Lucrative licensing business model includes agreements to enhance cannabinoid (CBD) delivery before year-end 2018 Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) and its proprietary technology found in the company’s drug delivery platform DehydraTECH has application for several subsets of the cannabis industry and other pharmacological verticals. As a technology proven to deliver increased intestinal absorption rates and higher bioavailability for a number of bioactive compounds,…

WednesdayOct 10, 2018 12:01 pm

ChineseInvestors.com, Inc.’s (CIIX) CBD Biotechnology Co. Ltd. Sets December Launch for CBD Hemp-Infused Rice Wine, Sees it as ‘Sales Driver’

CIIX’s wholly owned foreign enterprise, CBD Biotechnology Co. Ltd. (CBD Biotech), will debut new private label wine at peak period for liquor sales in China Company recorded sales of $2.35 million for FY2018, up 41 percent from $1.66 million the prior year Summer Yun, CEO of CBD Biotech, anticipates greater volume during the top sales season for liquor ChineseInvestors.com, Inc.’s (OTCQB: CIIX) CBD Biotech, a wholly owned foreign enterprise, plans to debut a CBD hemp-infused rice wine in December, during China’s peak holiday/festival season that includes Christmas, New Year’s, and Spring Festival (http://cnw.fm/cq9AQ). In a news release, Warren Wang, CEO of…

WednesdayOct 10, 2018 11:19 am

DEA Decision to Remove Some Cannabidiol from Most Restrictive Class of Controlled Substances May Have Far-Reaching Impact on the CBD Market

The U.S. Drug Enforcement Administration (DEA) ruling enables physicians to prescribe Epidiolex, a non-synthetic cannabis-derived medicine from United Kingdom-grown cannabis Cannabis entrepreneurs applaud the decision, even though it only applies to that specific drug; DEA decision requires approval of medications by the U.S. Food & Drug Administration (FDA) Several other CBD medications are in the pipeline for consideration by the FDA; move is seen as legitimizing the industry and changing it to traditional distribution of prescription-to-drug store The DEA decision to approve the first non-synthetic CBD-derived drug, Epidiolex, and remove it from the agency’s most restrictive class of controlled substances…

WednesdayOct 10, 2018 10:54 am

Green Hygienics Holdings Inc. (GRYN) Acquires Canna Brands Portfolio

The three online platforms provide a strategic step forward in advancing the company’s business model by creating tools to introduce the existing portfolio brands into vertical markets Again the company is setting itself apart by further demonstrating a unique business approach toward advancing operations and creating value in the sector The acquisition portfolio has the potential to generate substantial revenues on its own Full-scope premium cannabis company Green Hygienics Holdings Inc. (OTC: GRYN) recently announced that it has acquired the Canna Brands Portfolio. This acquisition centers on three core products: Cannagram, Myijuana and The CoursePro Academy. The full press release…

WednesdayOct 10, 2018 4:20 am

420 with CNW – Colorado Prosecutor Threatens Action Against Marijuana Businesses Violating the Law

U.S. Attorney Bob Troyer, the top federal prosecutor in Colorado, has vowed that his office will take firm action against any legal marijuana business that acts as a front for illegal activity, such as selling marijuana on the black market. Some growers in various states who are faced with excess production are alleged to have resorted to selling that extra produce to the illegal marijuana market rather than see that cannabis go to waste when the legal market cannot buy it all. Such firms are the next target of enforcement efforts. The attorney revealed that his office had mainly focused…